Medscape Education

My WebMD Sign In

Please enter email address

Enter your password

Keep me signed in on this computer

If you select "Keep me signed in on this computer", every time you visit WebMD.com you won't have to type your email address and password. This means that a cookie will stay on your computer even when you exit or close your browser which may reduce your levels of privacy and security. You should never select this option if you're using a publicly accessible computer, or if you're sharing a computer with others. Even if you select this option there are some features of our site that still require you to log in for privacy reasons.

Forget your password? Having trouble signing in?

Why should I
sign up for WebMD?

With a WebMD Account you can:

Track your way to weight loss success
Manage your family's vaccinations
Join the conversation

See more benefits Sign Up

Why WebMD?

My WebMD

Show Menu

Facebook Twitter Pinterest

Oncology Learning Centers

STOP AND THINK...
Could it be a rare disease?

Latest In Oncology

Filter

All U.S. Non-U.S.

Acute Leukemia 5005273 global 1 1.00 9 1.00 Hematology-Oncology CME / ABIM MOC 1.0 Journal Article 0 1

MRD at the End of Induction and EFS in T-Cell Lymphoblastic Lymphoma: Children’s Oncology Group Trial AALL1231

In pediatric T-cell lymphoblastic lymphoma, minimal residual disease at end of induction may predict event-free survival. Start activity

View Details

1.0Credits 60 MIN

Lung Cancer 5000186 global 1 1.25 2 1.25 3 1.25 9 1.25 Hematology-Oncology CME / ABIM MOC / CE 1.25 Roundtable 0 1

Targeted Therapy for Mutations

Can you keep up with all the targetable mutations in non-small cell lung cancer (NSCLC)? Start activity

View Details

1.25Credits 75 MIN

Prostate Cancer 3003438 global 1 1.25 2 1.25 3 1.25 9 1.25 Hematology-Oncology CME / ABIM MOC / CE 1.25 Roundtable 0 1

Expanding Therapeutic Options in De Novo Metastatic Hormone-Sensitive Prostate Cancer: Overcoming Resistance to Traditional Therapies

An expert panel delves into the nuances of care for expanding therapeutic options for patients with de novo metastatic hormone-sensitive prostate cancer (mHSPC). Start activity

Expanding Therapeutic Options in De Novo Metastatic Hormone-Sensitive Prostate Cancer: Overcoming Resistance to Traditional Therapies

View Details

1.25Credits 75 MIN

HR+ HER2- Breast Cancer 6016974 global 1 0.25 9 0.25 Hematology-Oncology CME / ABIM MOC 0.25 Clinical Review 0 1

Testing Your Knowledge on the Latest Recommendations for Managing Patients With HR-Positive, HER2-Negative EBC

Are you up to date on best practices for treating patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer (EBC)? Start activity

View Details

0.25Credits 15 MIN

0 global 1 0.75 2 0.75 3 0.75 9 0.75 Hematology-Oncology CME / ABIM MOC / CE 0.75 Roundtable 0 1

Antibody Drug Conjugates

Get the most up to date information on antibody drug conjugates (ADCs) in non-small cell lung cancer (NSCLC)! Start activity

View Details

0.75Credits 45 MIN

Paroxysmal Nocturnal Hemoglobinuria 5003734 global 2 1.25 Hematology-Oncology CE 1.25 Roundtable 0 1

Classical to Malignant Hematology: Overcoming Challenges That Nurses/NPs Face in the Clinic

How up to date are you on the nuances of integrating patient-centered care along the continuum of paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML)? Start activity

Classical to Malignant Hematology: Overcoming Challenges That Nurses/NPs Face in the Clinic

View Details

1.25Credits 75 MIN

View All

Curated Collections

Curated activities and resources from our partners and committee

View All

Topics

Credits

Format

Type

Featured Topics